News - Ligand Pharmaceuticals

Filter

Current filters:

Ligand Pharmaceuticals

Popular Filters

Ligand licenses five programs to Viking Therapeutics

23-05-2014

US drugmaker Ligand Pharmaceuticals has out-licensed rights to five programs to Viking Therapeutics,…

Cardio-vascularDiabetesFinancialLicensingLigand PharmaceuticalsMetabolicsPharmaceuticalViking Therapeutics

Ligand signs dyslipidemia related diseases accord with AstraZeneca unit

14-05-2014

US drugmaker Ligand Pharmaceuticals has entered into a licensing agreement and research collaboration…

AstraZenecaCardio-vascularLicensingLigand PharmaceuticalsOmthera PharmaceuticalsPharmaceuticalResearch

FDA accepts Lundbeck NDA for IV carbamazepine

FDA accepts Lundbeck NDA for IV carbamazepine

10-03-2014

The US subsidiary of Danish CNS specialist Lundbeck says that the Food and Drug Administration has accepted…

CarbamazepineCarbellaFinancialLigand PharmaceuticalsLundbeckNeurologicalNorth AmericaPharmaceuticalRegulationUSA

GSK files for US approval for Promacta for severe aplastic anemia

GSK files for US approval for Promacta for severe aplastic anemia

02-03-2014

UK pharma giant GlaxoSmithKline has submitted a supplemental New Drug Application to the US Food and…

GlaxoSmithKlineLigand PharmaceuticalsNorth AmericaOncologyPharmaceuticalPromactaRare diseasesRegulationUSA

US FDA backs Pfizer’s hot flashes drug Duavee

US FDA backs Pfizer’s hot flashes drug Duavee

04-10-2013

Pfizer and partner Ligand Pharmaceuticals say that the US Food and Drug Administration has approved Duavee,…

bazedoxifeneDuaveeLigand PharmaceuticalsNorth AmericaPfizerPharmaceuticalRegulationWomen's Health

Ligand signs deal with start-up CURx to develop first topiramate injection for epilepsy

15-08-2013

US drugmaker Ligand Pharmaceuticals (Nasdaq: LGND) has entered a global license agreement with start-up…

JanssenLicensingLigand PharmaceuticalsNeurologicalNorth AmericaPharmaceuticaltopiramate

Ligand enters global license deal for women's health product

23-07-2013

Ligand Pharmaceuticals (Nasdaq: LGND) announces the signing of a global license agreement with recently-formed…

Azure BiotechBiotechnologyGloballasofoxifeneLicensingLigand PharmaceuticalsPfizerPharmaceuticalWomen's Health

Ligand acquires financial rights to over 15 development programs from Selexis

01-05-2013

US drugmaker Ligand Pharmaceuticals (Nasdaq: LGND) has acquired a portfolio of potential future milestone…

BiotechnologyLigand PharmaceuticalsMergers & AcquisitionsResearchSelexis

Ligand to earn up to $50 million in deal with Spectrum for Captisol-enabled melphalan

14-03-2013

Ligand Pharmaceuticals (Nasdaq: LGND) has signed a global license and supply agreements with fellow US…

FinancialLicensingLigand PharmaceuticalsmelphalanOncologyPharmaceuticalSpectrum Pharmaceuticals

Ligand licenses DARA Program to Retrophin

21-02-2012

USA-based Ligand Pharmaceuticals (Nasdaq: LGND) has entered into an agreement in which it has licensed…

BiotechnologyDARALicensingLigand PharmaceuticalsNephrology and HepatologyPharmaceuticalRare diseasesResearchRetrophin

Ligand in deal with Chiva for global rights to Fablyn

12-10-2011

In a second deal with the company, Ligand Pharmaceuticals (Nasdaq: LGND) has entered into a global licensing…

Anti-Arthritics/RheumaticsChiva PharmaFablynLicensingLigand PharmaceuticalsPharmaceutical

Back to top